BRIEF published on 08/01/2024 at 15:58, 2 years 1 month ago SCOR : Déclaration sur les droits de vote et actions au 31 juillet 2024 Droits De Vote Capital Social AMF Réassurance SCOR
BRIEF published on 08/01/2024 at 15:58, 2 years 1 month ago SCOR: Declaration on voting rights and shares as of July 31, 2024 Share Capital Voting Rights Reinsurance AMF SCOR
BRIEF published on 08/01/2024 at 15:50, 2 years 1 month ago Issuer Direct Corporation to Host Second Quarter and Earnings Conference Call on August 8, 2024 Conference Call Webcast Replay Issuer Direct Quarterly Earnings
BRIEF published on 08/01/2024 at 15:50, 2 years 1 month ago Issuer Direct Corporation organisera une conférence téléphonique sur le deuxième trimestre et sur les résultats le 8 août 2024 Webdiffusion Conférence Téléphonique Émetteur Direct Gains Trimestriels Rejouer
BRIEF published on 08/01/2024 at 15:50, 2 years 1 month ago VETCOMM Reduces Costs and Improves Service for Veterans by Moving Call Center In-House Operational Efficiency Customer Service Cost Reduction VETCOMM Call Center
BRIEF published on 08/01/2024 at 15:50, 2 years 1 month ago VETCOMM réduit les coûts et améliore le service destiné aux anciens combattants en déplaçant le centre d'appels en interne Service Client Réduction Des Coûts Efficacité Opérationnelle VETCOMM Centre D'appel
BRIEF published on 08/01/2024 at 15:31, 2 years 1 month ago The Vanguard Group Announces Position in International Paper Company Form 8.3 The Vanguard Group Takeover Code Stock Disclosure International Paper
BRIEF published on 08/01/2024 at 15:31, 2 years 1 month ago Le groupe Vanguard annonce une position dans International Paper Company Le Groupe Vanguard Code De Reprise Formulaire 8.3 Papier International Divulgation Des Stocks
BRIEF published on 08/01/2024 at 15:30, 2 years 1 month ago Vanguard Group Discloses Position in Balanced Commercial Property Trust Financial Dealings Takeover Code Securities Disclosure Vanguard Group Balanced Commercial Property
BRIEF published on 08/01/2024 at 15:30, 2 years 1 month ago Vanguard Group divulgue une position dans une fiducie immobilière commerciale équilibrée Groupe D'avant-garde Code De Reprise Divulgation Des Titres Opérations Financières Propriété Commerciale Équilibrée
Published on 09/11/2026 at 17:00, 2 hours 42 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 2 hours 42 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 4 hours 17 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 4 hours 42 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 5 hours 12 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 18:15, 1 hour 26 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 1 hour 42 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 18:00, 1 hour 42 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 12 hours 42 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 12 hours 42 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 12 hours 42 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 12 hours 42 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
